Home Care Management of Pediatric Pain

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT00251628
Collaborator
National Institute of Nursing Research (NINR) (NIH)
211
1
3
141
1.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether around-the-clock dosing of pain medication, with or without nurse coaching, increases the effectiveness of pain management (i.e., decreased pain intensity scores with and without swallowing, increased use of pain medication, improved sleep, increased oral intake of fluids, decreased negative behaviors, and the same degree of side effects), over time, compared to standard care with "as needed" dosing.

Condition or Disease Intervention/Treatment Phase
  • Other: Standard Care
  • Other: ATC Dosing
  • Other: Structured Pain Management Program
  • Other: As needed dosing
Phase 4

Detailed Description

The undertreatment of postoperative pain in children remains a critical problem. Only recently have clinical trials begun to evaluate the efficacy of pharmacologic interventions in the management of postoperative pain beyond the immediate postoperative recovery period and after discharge home following tonsillectomy. Given the fact that approximately 50% of pediatric surgeries are done on an outpatient basis, this study has the potential to improve the home pain management of thousands of children. This study is one of the first to evaluate in a systematic fashion the use of an around-the-clock dosing of a weight appropriate dose of a nonopioid/opioid combination analgesic compared to as needed dosing. Because the study will evaluate the effectiveness of both a behavioral intervention and two different pharmacologic interventions, it will provide important information that should have a direct clinical application in the management of children's pain.

The consent form is written according to the standards outlined by the Committee on Human Research, including: 1) an explanation of the purposes of the research and the expected duration of the subject's participation; 2) a description of the procedures to be followed; 3) a description of any foreseeable risks or benefits to the subject, and any alternative courses of treatment; 4) a statement describing the extent to which confidentiality of records will be maintained; 5) a statement whether compensation will be provided and medical treatment made available if injury occurs; 6) the name and number of the Chair of the Committee on Human Research; 7) a statement that participation is voluntary, and that the subject may discontinue participation at any time; and 8) a statement indicating that the subject has received a copy of the consent document and related materials. A separate form is signed to authorize access to their health care information.

Study Design

Study Type:
Interventional
Actual Enrollment :
211 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Home Care Management of Pediatric Pain
Study Start Date :
Jun 1, 2000
Actual Primary Completion Date :
Mar 1, 2012
Actual Study Completion Date :
Mar 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group A

Other: Standard Care
standard care

Other: As needed dosing
"As needed" analgesic dosing with a weight-appropriate dose of a nonopioid/opioid combination analgesic, every 4 hours as needed for pain.

Active Comparator: Group B

Other: Standard Care
standard care

Other: ATC Dosing
ATC dosing of a weight-appropriate dose of a nonopioid/opioid combination analgesic, every 4 hours around-the-clock for the first 3 days following surgery

Experimental: Group C

Other: ATC Dosing
ATC dosing of a weight-appropriate dose of a nonopioid/opioid combination analgesic, every 4 hours around-the-clock for the first 3 days following surgery

Other: Structured Pain Management Program
The structured pain management program consisted of a nurse coaching intervention which included an evaluation of the child's current condition, review of the pain intensity scores, verification that the child was taking the pain medication, re-education regarding the rationale for ATC dosing, review of strategies to facilitate medication administration, and re-education about potential side effects associated with analgesic administration.

Outcome Measures

Primary Outcome Measures

  1. Determine the effectiveness of pain management "over time", compared to standard care with "as needed" dosing. [Morning and evening for 3 days following surgery]

Secondary Outcome Measures

  1. Pain intensity [Morning and evening for 3 days following surgery]

  2. Severity of opioid-related adverse effects (i.e., nausea, vomiting, constipation, daytime sedation, lightheadedness or feeling dizzy, and nightmares) [Every evening for 3 days following surgery]

  3. Volume and number of times pain medication administered [with each dose for 3 days following surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Outpatient tonsillectomy, with or without other minor procedures (e.g., ear tube placement); parental consent; child assent (age-appropriate); ability of the child to speak English; ability of the parents to read, write, and speak English; and, access to a telephone.
Exclusion Criteria:
  • History of severe obstructive sleep apnea (causing the child to stop breathing repeatedly during sleep); known problems with vision, hearing, control and coordination of movement, or thinking ability.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital Central California Madera California United States 93638-8762

Sponsors and Collaborators

  • University of California, San Francisco
  • National Institute of Nursing Research (NINR)

Investigators

  • Principal Investigator: Kimberly A Sutters, RN, PhD, Children's Hospital Central California

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kimberly A. Sutters, Kimberly A. Sutters, RN, PhD, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00251628
Other Study ID Numbers:
  • CHR #H7097-14918-13
  • R01NR004826
First Posted:
Nov 10, 2005
Last Update Posted:
Jun 8, 2012
Last Verified:
Jun 1, 2012
Keywords provided by Kimberly A. Sutters, Kimberly A. Sutters, RN, PhD, University of California, San Francisco

Study Results

No Results Posted as of Jun 8, 2012